キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/09/17 | 2,596 | 2,596 | 2,533 | 2,538 | -62 | -2.4% | 199,700 |
2021/09/16 | 2,574 | 2,613 | 2,566 | 2,600 | +32 | +1.2% | 80,100 |
2021/09/15 | 2,591 | 2,622 | 2,565 | 2,568 | -68 | -2.6% | 115,500 |
2021/09/14 | 2,610 | 2,641 | 2,594 | 2,636 | +16 | +0.6% | 102,600 |
2021/09/13 | 2,586 | 2,620 | 2,565 | 2,620 | +13 | +0.5% | 83,900 |
2021/09/10 | 2,558 | 2,607 | 2,544 | 2,607 | +73 | +2.9% | 158,700 |
2021/09/09 | 2,524 | 2,570 | 2,521 | 2,534 | -8 | -0.3% | 77,000 |
2021/09/08 | 2,529 | 2,559 | 2,529 | 2,542 | +18 | +0.7% | 81,800 |
2021/09/07 | 2,509 | 2,538 | 2,508 | 2,524 | +14 | +0.6% | 98,800 |
2021/09/06 | 2,520 | 2,530 | 2,501 | 2,510 | +14 | +0.6% | 70,500 |
2021/09/03 | 2,456 | 2,503 | 2,451 | 2,496 | +45 | +1.8% | 78,400 |
2021/09/02 | 2,450 | 2,455 | 2,424 | 2,451 | +1 | ±0% | 49,700 |
2021/09/01 | 2,421 | 2,450 | 2,404 | 2,450 | +28 | +1.2% | 75,300 |
2021/08/31 | 2,391 | 2,436 | 2,382 | 2,422 | -1 | ±0% | 66,800 |
2021/08/30 | 2,399 | 2,431 | 2,396 | 2,423 | +23 | +1% | 47,100 |
2021/08/27 | 2,400 | 2,410 | 2,393 | 2,400 | ±0 | ±0% | 45,900 |
2021/08/26 | 2,365 | 2,418 | 2,365 | 2,400 | -8 | -0.3% | 65,600 |
2021/08/25 | 2,403 | 2,422 | 2,385 | 2,408 | -8 | -0.3% | 69,200 |
2021/08/24 | 2,391 | 2,426 | 2,383 | 2,416 | +19 | +0.8% | 83,900 |
2021/08/23 | 2,396 | 2,420 | 2,396 | 2,397 | +22 | +0.9% | 58,700 |
2021/08/20 | 2,342 | 2,376 | 2,337 | 2,375 | +28 | +1.2% | 73,200 |
2021/08/19 | 2,334 | 2,350 | 2,322 | 2,347 | +29 | +1.3% | 56,900 |
2021/08/18 | 2,323 | 2,334 | 2,307 | 2,318 | +1 | ±0% | 48,300 |
2021/08/17 | 2,324 | 2,348 | 2,309 | 2,317 | -1 | ±0% | 43,200 |
2021/08/16 | 2,339 | 2,347 | 2,307 | 2,318 | -38 | -1.6% | 72,200 |
2021/08/13 | 2,327 | 2,356 | 2,327 | 2,356 | +18 | +0.8% | 52,100 |
2021/08/12 | 2,333 | 2,342 | 2,315 | 2,338 | +9 | +0.4% | 38,400 |
2021/08/11 | 2,320 | 2,333 | 2,318 | 2,329 | +21 | +0.9% | 49,300 |
2021/08/10 | 2,300 | 2,324 | 2,295 | 2,308 | +8 | +0.3% | 44,300 |
2021/08/06 | 2,283 | 2,320 | 2,283 | 2,300 | -18 | -0.8% | 49,700 |
2021/08/05 | 2,291 | 2,329 | 2,289 | 2,318 | +10 | +0.4% | 45,300 |
2021/08/04 | 2,327 | 2,337 | 2,304 | 2,308 | -29 | -1.2% | 73,100 |
2021/08/03 | 2,285 | 2,361 | 2,280 | 2,337 | +34 | +1.5% | 97,100 |
2021/08/02 | 2,257 | 2,307 | 2,255 | 2,303 | +58 | +2.6% | 79,800 |
2021/07/30 | 2,260 | 2,264 | 2,227 | 2,245 | -17 | -0.8% | 90,200 |
2021/07/29 | 2,280 | 2,283 | 2,253 | 2,262 | -1 | ±0% | 48,000 |
2021/07/28 | 2,269 | 2,279 | 2,257 | 2,263 | -30 | -1.3% | 39,600 |
2021/07/27 | 2,295 | 2,295 | 2,264 | 2,293 | +23 | +1% | 53,000 |
2021/07/26 | 2,295 | 2,299 | 2,253 | 2,270 | +1 | ±0% | 45,300 |
2021/07/21 | 2,276 | 2,290 | 2,253 | 2,269 | +11 | +0.5% | 69,800 |
2021/07/20 | 2,231 | 2,262 | 2,228 | 2,258 | +27 | +1.2% | 65,300 |
2021/07/19 | 2,228 | 2,239 | 2,211 | 2,231 | -17 | -0.8% | 71,800 |
2021/07/16 | 2,254 | 2,286 | 2,246 | 2,248 | -16 | -0.7% | 59,500 |
2021/07/15 | 2,287 | 2,300 | 2,261 | 2,264 | -26 | -1.1% | 74,600 |
2021/07/14 | 2,240 | 2,290 | 2,236 | 2,290 | +31 | +1.4% | 71,700 |
2021/07/13 | 2,240 | 2,270 | 2,239 | 2,259 | +40 | +1.8% | 97,600 |
2021/07/12 | 2,222 | 2,225 | 2,196 | 2,219 | +69 | +3.2% | 98,800 |
2021/07/09 | 2,119 | 2,151 | 2,109 | 2,150 | +11 | +0.5% | 105,000 |
2021/07/08 | 2,136 | 2,165 | 2,136 | 2,139 | -3 | -0.1% | 85,100 |
2021/07/07 | 2,132 | 2,158 | 2,122 | 2,142 | -23 | -1.1% | 56,600 |
901~
950
件表示中 / 3707件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 395,500円 | +3.6% | +6.1% | 3.03% | 13.32倍 | 0.78倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サワイGHD | 180,300円 | +5.9% | +24.5% | 3.05% | 11.97倍 | 1.13倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ジーエヌアイ | 418,000円 | +21.7% | +999.9% | 0.00% | 17.51倍 | 5.79倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.35倍 | 1.47倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 376,600円 | -6.4% | -71.8% | 5.05% | 41.94倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム